Abstract
Purpose
There were contrary results about the effects of hepatitis B e antigen (HBeAg) positivity on the long-term survival in patients with hepatocellular carcinoma (HCC) after curative resection.
Patients and Methods
Medical records of 170 HCC patients who underwent curative liver resections were retrospectively reviewed. The 10-year survival rate and correlations among clinical, laboratory, and pathological data, especially HBeAg, were analyzed.
Results
Fifty-two patients survived more than 10 years. The 10-year actual overall survival (OS) rate was 30.6%, and the actual disease-free survival (DFS) rate was 24.1%. The median OS and DFS were 76 and 35 months, respectively. In multivariate analysis, HBeAg positivity (P = 0.032; hazard ratio [HR], 3.041), presence of a satellite nodule (P = 0.007; HR, 4.166), and elevated ICG R15 (P = 0.003; HR, 4.915) had a significant negative correlation with the 10-year DFS rate. In addition, HBeAg positivity (P = 0.044; HR, 3.725) and recurrence (recur within 1 year, P < 0.001; HR, 41.296; recur after 1 year, P = 0.03; HR, 4.848) were found as independent factors which were negatively correlated to the 10-year OS.
Conclusions
The presence of HBeAg was significantly correlated to DFS and OS after curative resection for HCC. Active treatment of B viral hepatitis before and after surgery should be provided to prolong survival in patients with 5–10-cm HCC.
Similar content being viewed by others
References
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55(2):74-108.
Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette Smoking, Alcohol Drinking, Hepatitis B, and Risk for Hepatocellular Carcinoma in Korea. J. Natl. Cancer Inst. 2004;96(24):1851-1856.
Office KNS. 2008 The statistical results for the cause of death. 2009
Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000;32(6):1224-1229.
Boutros C, Somasundar P, Garrean S, Saied A, Espat NJ. Microwave coagulation therapy for hepatic tumors: Review of the literature and critical analysis. Surgical Oncology 2010;19(1):e22-e32.
Mahnken AH, Bruners P, Gunther RW. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation. Dig Dis 2009;27(2):148-156.
Yamamoto J, Okada S, Shimada K, et al. Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001;34(4):707-713.
Hasegawa K, Makuuchi M, Takayama T, et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008;49(4):589-594.
Schwarz RE, Smith DD. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg 2008;195(6):829-836.
Josep LL, Andrew B, Jordi B. Hepatocellular carcinoma. The Lancet 2003;362(9399):1907.
Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25(2):181-200.
Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002;235(4):533-539.
Sharma P, Balan V, Hernandez JL, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004;10(1):36-41.
Foster JH, Berman MM. Solid liver tumors. Major problems in clinical surgery 1977;22:1-342.
Belghiti J, Hiramatsu K, Benoist S, Massault PP, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990 s: An update to evaluate the actual risk of liver resection. Journal of the American College of Surgeons 2000;191(1):38-46.
Imamura H, Seyama Y, Kokudo N, et al. One Thousand Fifty-Six Hepatectomies without Mortality in 8 Years. Archives of Surgery 2003;138(11):1198-1206.
Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: Analysis of 1,803 consecutive cases over the past decade. Annals of Surgery 2002;236(4):397-407.
Metcalfe MS, Mullin EJ, Maddern GJ. Hepatectomy for metastatic noncolorectal gastrointestinal, breast and testicular tumours. ANZ Journal of Surgery 2006;76(4):246-250.
Truty MJ, Vauthey JN. Surgical resection of high-risk hepatocellular carcinoma: Patient selection, preoperative considerations, and operative technique. Annals of Surgical Oncology 2010;17(5):1219-1225.
Takano S, Oishi H, Kono S, et al. Retrospective analysis of type of hepatic resection for hepatocellular carcinoma. Br J Surg 2000;87(1):65-70.
Chang CH, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 2004;139(3):320-325; discussion 326.
Choi YM, Kang KC, Ahn SI, Lee KY, Hong KC, Choi SK. Clinical Analysis of Prognostic Factors in Hepatocellular Carcinoma. J Korean Surg Soc 2003;65:42-48.
Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 2000;191(4):381-388.
Hwang IS, Hong SW, Nah YW, Jang YG, Kim KH, Lee H. Analysis of 38 Long-Term Survivors after Liver resections for Hepatocellular Carcinomas. . Korean J HBP Surg 2000;4(2):67-76.
Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery 2002;131(1 Suppl):S153-158.
Shimozawa N, Hanazaki K. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 2004;198(3):356-365.
Nagasue N, Kohno H, Chang YC, et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993;217(4):375-384.
Shimada K, Sano T, Sakamoto Y, Kosuge T. A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer 2005;104(9):1939-1947.
Lee JG, Kang CM, Park JS, et al. The actual five-year survival rate of hepatocellular carcinoma patients after curative resection. Yonsei Med J 2006;47(1):105-112.
Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006;202(2):275-283.
Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 1991;14(5):802-805.
Fukuda S, Itamoto T, Amano H, et al. Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy. World Journal of Surgery 2007;31(2):345-352.
Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Annals of Surgery 1991;214(2):114-117.
Paquet KJ, Koussouris P, Mercado MA, Kalk -Fr J, Muting D, Rambach W. Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: A prospective study. British Journal of Surgery 1991;78(4):459-462.
Yasui M, Harada A, Torii A, Nakao A, Nonami T, Takagi H. Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma. World Journal of Surgery 1995;19(3):439-443.
Hanazaki K, Matsushita A, Nakagawa K, Misawa R, Amano J. Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma. Hepatogastroenterology 2005;52(62):552-557.
Adachi E, Maeda T, Matsumata T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995;108(3):768-775.
Shirabe K, Shimada M, Kajiyama K, et al. Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection. Cancer 1998;83(11):2312-2316.
Cescon M, Cucchetti A, Grazi GL, et al. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience. Arch Surg 2009;144(10):906-913.
Sun H-C, Zhang W, Qin L-X, et al. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. Journal of Hepatology 2007;47(5):684-690.
Wu JC, Huang YH, Chau GY, et al. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 2009;51(5):890-897.
Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 2006;243(2):229-235.
Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232(1):10-24.
Author information
Authors and Affiliations
Corresponding author
Additional information
Grant Support
This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A084120).
Rights and permissions
About this article
Cite this article
Kim, S.H., Choi, S.B., Lee, J.G. et al. Prognostic Factors and 10-Year Survival in Patients with Hepatocellular Carcinoma After Curative Hepatectomy. J Gastrointest Surg 15, 598–607 (2011). https://doi.org/10.1007/s11605-011-1452-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-011-1452-7